McKesson 2016 Annual Report Download - page 9

Download and view the complete annual report

Please find page 9 of the 2016 McKesson annual report below. You can navigate through the pages in the report by either clicking on the pages listed below, or by using the keyword search tool below to find specific information within the annual report.

Page out of 156

  • 1
  • 2
  • 3
  • 4
  • 5
  • 6
  • 7
  • 8
  • 9
  • 10
  • 11
  • 12
  • 13
  • 14
  • 15
  • 16
  • 17
  • 18
  • 19
  • 20
  • 21
  • 22
  • 23
  • 24
  • 25
  • 26
  • 27
  • 28
  • 29
  • 30
  • 31
  • 32
  • 33
  • 34
  • 35
  • 36
  • 37
  • 38
  • 39
  • 40
  • 41
  • 42
  • 43
  • 44
  • 45
  • 46
  • 47
  • 48
  • 49
  • 50
  • 51
  • 52
  • 53
  • 54
  • 55
  • 56
  • 57
  • 58
  • 59
  • 60
  • 61
  • 62
  • 63
  • 64
  • 65
  • 66
  • 67
  • 68
  • 69
  • 70
  • 71
  • 72
  • 73
  • 74
  • 75
  • 76
  • 77
  • 78
  • 79
  • 80
  • 81
  • 82
  • 83
  • 84
  • 85
  • 86
  • 87
  • 88
  • 89
  • 90
  • 91
  • 92
  • 93
  • 94
  • 95
  • 96
  • 97
  • 98
  • 99
  • 100
  • 101
  • 102
  • 103
  • 104
  • 105
  • 106
  • 107
  • 108
  • 109
  • 110
  • 111
  • 112
  • 113
  • 114
  • 115
  • 116
  • 117
  • 118
  • 119
  • 120
  • 121
  • 122
  • 123
  • 124
  • 125
  • 126
  • 127
  • 128
  • 129
  • 130
  • 131
  • 132
  • 133
  • 134
  • 135
  • 136
  • 137
  • 138
  • 139
  • 140
  • 141
  • 142
  • 143
  • 144
  • 145
  • 146
  • 147
  • 148
  • 149
  • 150
  • 151
  • 152
  • 153
  • 154
  • 155
  • 156

McKESSON CORPORATION
PART I
Item 1. Business.
General
McKesson Corporation (“McKesson,” the “Company,” the “Registrant” or “we” and other similar
pronouns) is a global pharmaceutical distribution services and information technology company, currently ranked
11th on the Fortune 500. We deliver a comprehensive offering of pharmaceuticals and medical supplies and
provide services to help our customers improve the efficiency and effectiveness of their healthcare operations.
We work with payers, healthcare providers, pharmacies, pharmaceutical companies and others across the
healthcare industry to improve patients’ access to high-quality care and make healthcare safer while enhancing
efficiency and reducing costs.
The Company’s fiscal year begins on April 1 and ends on March 31. Unless otherwise noted, all references
in this document to a particular year shall mean the Company’s fiscal year.
Our Annual Report on Form 10-K, Quarterly Reports on Form 10-Q, Current Reports on Form 8-K and
amendments to those reports filed or furnished pursuant to Section 13(a) or 15(d) of the Securities Exchange Act
of 1934, as amended (the “Exchange Act,”) are available free of charge on our website (www.mckesson.com
under the “Investors — Financial Information — SEC Filings” caption) as soon as reasonably practicable after
we electronically file such material with, or furnish it to, the Securities and Exchange Commission (“SEC” or the
“Commission”). The content on any website referred to in this Annual Report on Form 10-K is not incorporated
by reference into this report, unless expressly noted otherwise.
The public may also read or copy any materials that we file with the SEC at the SEC’s Public Reference
Room at 100 F Street, N.E., Washington, DC 20549. The public may obtain information on the operation of the
Public Reference Room by calling the SEC at 1-800-SEC-0330. The SEC maintains a website that contains
reports, proxy and information statements, and other information regarding issuers, including the Company, that
file electronically with the SEC. The address of the website is www.sec.gov.
Business Segments
We operate our business through two segments: McKesson Distribution Solutions and McKesson
Technology Solutions.
Our Distribution Solutions segment distributes branded and generic pharmaceutical drugs and other
healthcare-related products worldwide and provides practice management, technology, clinical support and
business solutions to community-based oncology and other specialty practices. This segment also provides
specialty pharmaceutical solutions for pharmaceutical manufacturers including offering multiple distribution
channels and clinical trial access to our network of oncology physicians. It also provides medical-surgical supply
distribution, equipment, logistics and other services to healthcare providers within the United States.
Additionally, this segment operates retail pharmacies in Europe and supports independent pharmacy networks
within North America. It also sells financial, operational and clinical solutions to pharmacies (retail, hospital,
alternate site) and provides consulting, outsourcing and other services.
The Technology Solutions segment delivers enterprise-wide clinical, patient care, financial, supply chain
and strategic management technology solutions, as well as connectivity, outsourcing and other services,
including remote hosting and managed services, to healthcare organizations.
3